Your browser doesn't support javascript.
loading
Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma.
Bagnasco, Diego; Caminati, Marco; Ferrando, Matteo; Aloè, Teresita; Testino, Elisa; Canonica, Giorgio Walter; Passalacqua, Giovanni.
  • Bagnasco D; Allergy & Respiratory Diseases, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Caminati M; Asthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy.
  • Ferrando M; Allergy & Respiratory Diseases, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Aloè T; Allergy & Respiratory Diseases, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Testino E; Allergy & Respiratory Diseases, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Canonica GW; Allergy & Respiratory Diseases, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Passalacqua G; Department of Internal Medicine, Respiratory Disease Clinic, IRCCS, Humanitas Clinical and Research Center, Humanitas University, Rozzano, Milan, Italy.
Biomed Res Int ; 2018: 5698212, 2018.
Article en En | MEDLINE | ID: mdl-30519580
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Interleucina-5 / Antiasmáticos / Subunidad alfa del Receptor de Interleucina-5 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Interleucina-5 / Antiasmáticos / Subunidad alfa del Receptor de Interleucina-5 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article